229 related articles for article (PubMed ID: 17276525)
61. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
Morissette G; Bouthillier J; Marceau F
Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
[TBL] [Abstract][Full Text] [Related]
62. NSAID zaltoprofen possesses novel anti-nociceptive mechanism through blockage of B2-type bradykinin receptor in nerve endings.
Matsumoto M; Inoue M; Ueda H
Neurosci Lett; 2006 Apr; 397(3):249-53. PubMed ID: 16406342
[TBL] [Abstract][Full Text] [Related]
63. Characterization of the B2 receptor and activity of bradykinin analogs in SHP-77 cell line by Cytosensor microphysiometer.
Bironaite D; Gera L; Stewart JM
Chem Biol Interact; 2004 Dec; 150(3):283-93. PubMed ID: 15560894
[TBL] [Abstract][Full Text] [Related]
64. Contribution of B(2) receptors for bradykinin in arthus reaction-induced plasma extravasation in wild-type or B(2) transgenic knockout mice.
Samadfam R; Teixeira C; Bkaily G; Sirois P; de Brum-Fernandes A; D'Orleans-Juste P
Br J Pharmacol; 2000 Apr; 129(8):1732-8. PubMed ID: 10780980
[TBL] [Abstract][Full Text] [Related]
65. Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum.
Kam YL; Ro JY; Kim HJ; Choo HY
Eur J Pharmacol; 2005 Oct; 523(1-3):143-50. PubMed ID: 16226247
[TBL] [Abstract][Full Text] [Related]
66. Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury.
Souza DG; Pinho V; Pesquero JL; Lomez ES; Poole S; Juliano L; Correa A; de A Castro MS; Teixeira MM
Br J Pharmacol; 2003 May; 139(1):129-39. PubMed ID: 12746231
[TBL] [Abstract][Full Text] [Related]
67. Discovery of the first non-peptide full agonists for the human bradykinin B(2) receptor incorporating 4-(2-picolyloxy)quinoline and 1-(2-picolyl)benzimidazole frameworks.
Sawada Y; Kayakiri H; Abe Y; Mizutani T; Inamura N; Asano M; Hatori C; Aramori I; Oku T; Tanaka H
J Med Chem; 2004 May; 47(11):2853-63. PubMed ID: 15139763
[TBL] [Abstract][Full Text] [Related]
68. Stimulatory effect of bradykinin (BK) on glucagon secretion from the perfused rat pancreas: involvement of BK2 receptors.
Abu-Basha EA; Makowski JP; Yibchok-anun S; Hsu WH
Metabolism; 2000 Oct; 49(10):1370-3. PubMed ID: 11079832
[TBL] [Abstract][Full Text] [Related]
69. Assessment of TNFalpha contribution to the functional up-regulation of kinin B(1) receptors in the mouse paw after treatment with LPS.
Rocha AC; Fernandes ES; Passos GF; Calixto JB; Campos MM
Int Immunopharmacol; 2005 Oct; 5(11):1593-600. PubMed ID: 16039549
[TBL] [Abstract][Full Text] [Related]
70. Involvement of CPI-17 downregulation in the dysmotility of the colon from dextran sodium sulphate-induced experimental colitis in a mouse model.
Sato K; Ohkura S; Kitahara Y; Ohama T; Hori M; Sato M; Kobayashi S; Sasaki Y; Hayashi T; Nasu T; Ozaki H
Neurogastroenterol Motil; 2007 Jun; 19(6):504-14. PubMed ID: 17564632
[TBL] [Abstract][Full Text] [Related]
71. Pharmacological characterization of the bradykinin B2 receptor antagonist MEN16132 in rat in vitro bioassays.
Meini S; Cucchi P; Catalani C; Bellucci F; Giuliani S; Santicioli P; Maggi CA
Eur J Pharmacol; 2009 Aug; 615(1-3):10-6. PubMed ID: 19445925
[TBL] [Abstract][Full Text] [Related]
72. Potentiation of des-Arg9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery.
Pelorosso FG; Brodsky PT; Zold CL; Rothlin RP
J Pharmacol Exp Ther; 2005 Jun; 313(3):1355-60. PubMed ID: 15764737
[TBL] [Abstract][Full Text] [Related]
73. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.
Gougat J; Ferrari B; Sarran L; Planchenault C; Poncelet M; Maruani J; Alonso R; Cudennec A; Croci T; Guagnini F; Urban-Szabo K; Martinolle JP; Soubrié P; Finance O; Le Fur G
J Pharmacol Exp Ther; 2004 May; 309(2):661-9. PubMed ID: 14747609
[TBL] [Abstract][Full Text] [Related]
74. Bradykinin-induced expression of alpha-smooth muscle actin in human mesenchymal stem cells.
Kim YM; Jeon ES; Kim MR; Lee JS; Kim JH
Cell Signal; 2008 Oct; 20(10):1882-9. PubMed ID: 18655827
[TBL] [Abstract][Full Text] [Related]
75. Effect of allelic polymorphism of the B(1) and B(2) receptor genes on the contractile responses of the human umbilical vein to kinins.
Houle S; Landry M; Audet R; Bouthillier J; Bachvarov DR; Marceau F
J Pharmacol Exp Ther; 2000 Jul; 294(1):45-51. PubMed ID: 10871294
[TBL] [Abstract][Full Text] [Related]
76. Differences between peptide and nonpeptide B(2) bradykinin receptor antagonists in blocking bronchoconstriction and hypotension induced by bradykinin in anesthetized Guinea pigs.
Tramontana M; Lecci A; Meini S; Montserrat X; Pascual J; Giuliani S; Quartara L; Maggi CA
J Pharmacol Exp Ther; 2001 Mar; 296(3):1051-7. PubMed ID: 11181940
[TBL] [Abstract][Full Text] [Related]
77. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
Bai A; Guo Y; Lu N
Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
[TBL] [Abstract][Full Text] [Related]
78. Study of the mechanisms involved in the bradykinin-induced contraction of the pig iris sphincter muscle in vitro.
El Sayah M; Calixto JB
Eur J Pharmacol; 2003 Jan; 458(1-2):175-81. PubMed ID: 12498923
[TBL] [Abstract][Full Text] [Related]
79. Fate of bradykinin on the rat liver when administered by the venous or arterial route.
Gioli-Pereira L; Nascimento EA; Santos EL; Bracht A; Juliano MA; Pesquero JB; Borges DR; Kouyoumdjian M
J Gastroenterol Hepatol; 2005 Mar; 20(3):463-73. PubMed ID: 15740493
[TBL] [Abstract][Full Text] [Related]
80. N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes.
Gera L; Roy C; Bawolak MT; Charest-Morin X; Marceau F
Peptides; 2012 Apr; 34(2):433-46. PubMed ID: 22349904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
